Nisha Pandey

Health and Me

Australia Approves First GLP-1 Weight Loss Pill: How It Works & Who Is Eligible

Novo Nordisk’s GLP-1 weight loss pill, <span>Wegovy</span>, has been approved in <span>Australia</span> for sale. An alternative to weekly weight loss injections, the <span>Therapeutic Goods Administration</span> (<span>TGA</span>) has cleared Wegovy, which contains semaglutide, the same active ingredient found in GLP-1 weight loss injections: <span>Wegovy and Ozempic</span>.

The pill received TGA approval on November 3, 2026, expecting to reach the shelves by Christmas. 

It is prescribed to eligible adults to help manage chronic obesity along with lifestyle changes. It is also approved to reduce the risk of major cardiovascular events in eligible patients.

Until now, Australians seeking GLP-1 medication for weight management have primarily had access to injectable formulations. The tablet offers a different approach. 

<h2>How Does The <span rel="noindex">Wegovy Weight Loss Pill</span> Work?</h2>

Also read: <a href="https://www.healthandme.com/health-news/eli-lilly-can-continue-zepbound-ads-despite-novo-nordisks-claims-over-weight-loss-drug-comparisons-article-156412005" data-type="tilCustomLink">Eli Lilly Can Continue Zepbound Ads Despite Novo Nordisk’s Claims Over Weight-Loss Drug Comparisons</a>

The new tablet contains semaglutide, a <a href="https://www.healthandme.com/health-news/retatrutide-driving-peptide-linked-emergency-hospital-visits-in-australia-what-are-the-risks-article-156365185" data-type="tilCustomLink">GLP-1 receptor agonist</a> that mimics the action of the naturally occurring glucagon-like peptide-1 hormone.

GLP-1 medications act on appetite regulation. They help users feel full, reduce cravings and slow stomach emptying, which can lead to lower calorie intake and weight loss.

Unlike injectable Wegovy, which is administered once a week, this tablet should be taken every day.

The TGA has approved four tablet strengths for sale: 1.5 mg, 4 mg, 9 mg and 25 mg. Treatment starts at a lower dose, which is gradually increased over approximately 16 weeks under medical supervision. The tablet also has specific use requirements. Patients must:

<ul><li>Take it first thing in the morning on an empty stomach.</li><li>Swallow it with a small amount of water.</li><li>Avoid eating, drinking or taking other oral medications for at least 30 minutes afterwards.</li></ul>

The fasting instructions are important because semaglutide is absorbed less efficiently when taken orally. So following that instruction is crucial as a 25 mg tablet has to achieve an effect comparable to the 2.4 mg weekly injectable Wegovy dose.

<h2>Eligibility For GLP-1 Weight Loss Pill In Australia</h2>

Also read: <a href="https://www.healthandme.com/health-wellness/is-ozempic-face-influencing-the-beauty-industry-global-cosmetic-brand-highlights-a-new-trend-amid-glp-1-boom-article-156390682" data-type="tilCustomLink">Is ‘Ozempic Face’ Influencing The Beauty Industry? Global Cosmetic Brand Highlights A New Trend Amid GLP-1 Boom</a>

The TGA approval covers adults who meet specific weight-related criteria. These include:

<ul><li>Adults with <a href="https://www.healthandme.com/health-wellness/sorority-rush-sees-ozempic-trend-what-young-women-should-know-before-using-glp-1-drugs-article-156330563" data-type="tilCustomLink">obesity</a>, defined as a body mass index (<span rel="noindex">BMI</span>) of 30 or higher.</li><li>Adults who are overweight, with a BMI between 27 and 30, and have at least one weight-related health condition.</li></ul>

These conditions may include high blood pressure, abnormal cholesterol levels, type 2 diabetes, fatty liver disease or other weight-related complications.

The medication is also approved to reduce the risk of major adverse cardiovascular events in eligible adults with cardiovascular disease and those who are overweight or obese but don’t have diabetes.

However, approval does not mean everyone meeting these criteria should automatically take the medication. A doctor must assess your health, medical history, and risks before prescribing it.

Dr Brendan Hanrahan, an obesity medicine specialist at Brisbane's Wesley Hospital, welcomed wider access to the medication, saying GLP-1 drugs have "lived up to and exceeded the hype". However, he questioned whether BMI alone is enough to determine eligibility.

He suggested waist circumference could offer some information about health risks, saying that some people may experience complications related to weight even when their BMI falls within the ‘normal’ healthy range.

<h2>Side Effects And Risks Of Wegovy</h2>

Gut Health Under Threat? Experts Reveal the Biggest Risks, From Obesity to Cancer

The oral pill does not eliminate the side effects associated with <a href="https://www.healthandme.com/fitness/ozempic-could-reduce-cancer-risk-everything-you-need-to-know-article-151107424" data-type="tilCustomLink">semaglutide</a>. Common adverse effects include:

<ul><li>Nausea</li><li>Vomiting</li><li>Diarrhoea</li><li>Constipation</li><li>Abdominal discomfort</li><li>Headache</li><li>Fatigue</li><li>Dizziness</li></ul>

Gastrointestinal symptoms can sometimes lead to dehydration, which may increase the risk of kidney problems.

The TGA also warns about more serious complications, including acute pancreatitis and diabetic retinopathy. People with diabetes, particularly those with pre-existing eye disease, may need clinical monitoring.

Semaglutide is not recommended during pregnancy, and people planning to become pregnant should discuss treatment and timing with their doctor.

The TGA has also warned of depression and suicidal thoughts or behaviours linked with GLP-1 medications.

Health Conditions A-Z

health

australia-approves-first-glp-1-weight-loss-pill-how-it-works-who-is-eligible

australia

wegovy and ozempic

wegovy

therapeutic goods administration

wegovy pills

wegovy side effects

wegovy novo nordisk

wegovy weight loss pill

beth-dobbins-myalgic-encephalomyelitis-campaign-gains-support-from-360-sportspeople-why-are-they-urging-uk-pm-to-act

Beth Dobbin's Myalgic Encephalomyelitis Campaign Gains Support From 360 Sportspeople: Why Are They Urging UK PM To Act?

early-breast-cancer-how-to-make-space-for-treatment-without-losing-sight-of-yourself

Early Breast Cancer: How to Make Space for Treatment Without Losing Sight of Yourself

Health & Wellness

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

Novo Nordisk’s GLP-1 weight loss pill, Wegovy, has been approved in Australia for sale. An alternative to weekly weight loss injections, the Therapeutic Goods Administration (TGA) has cleared Wegovy, which contains semaglutide, the same active ingredient found in GLP-1 weight loss injections: Wegovy and Ozempic.The pill received TGA approval on November 3, 2026, expecting to reach the shelves by Christmas. It is prescribed to eligible adults to help manage chronic obesity along with lifestyle changes. It is also approved to reduce the risk of major cardiovascular events in eligible patients.Until now, Australians seeking GLP-1 medication for weight management have primarily had access to injectable formulations. The tablet offers a different approach. How Does The Wegovy Weight Loss Pill Work?Also read: Eli Lilly Can Continue Zepbound Ads Despite Novo Nordisk’s Claims Over Weight-Loss Drug ComparisonsThe new tablet contains semaglutide, a GLP-1 receptor agonist that mimics the action of the naturally occurring glucagon-like peptide-1 hormone.GLP-1 medications act on appetite regulation. They help users feel full, reduce cravings and slow stomach emptying, which can lead to lower calorie intake and weight loss.Unlike injectable Wegovy, which is administered once a week, this tablet should be taken every day.The TGA has approved four tablet strengths for sale: 1.5 mg, 4 mg, 9 mg and 25 mg. Treatment starts at a lower dose, which is gradually increased over approximately 16 weeks under medical supervision. The tablet also has specific use requirements. Patients must:Take it first thing in the morning on an empty stomach.Swallow it with a small amount of water.Avoid eating, drinking or taking other oral medications for at least 30 minutes afterwards.The fasting instructions are important because semaglutide is absorbed less efficiently when taken orally. So following that instruction is crucial as a 25 mg tablet has to achieve an effect comparable to the 2.4 mg weekly injectable Wegovy dose.Eligibility For GLP-1 Weight Loss Pill In AustraliaAlso read: Is ‘Ozempic Face’ Influencing The Beauty Industry? Global Cosmetic Brand Highlights A New Trend Amid GLP-1 BoomThe TGA approval covers adults who meet specific weight-related criteria. These include:Adults with obesity, defined as a body mass index (BMI) of 30 or higher.Adults who are overweight, with a BMI between 27 and 30, and have at least one weight-related health condition.These conditions may include high blood pressure, abnormal cholesterol levels, type 2 diabetes, fatty liver disease or other weight-related complications.The medication is also approved to reduce the risk of major adverse cardiovascular events in eligible adults with cardiovascular disease and those who are overweight or obese but don’t have diabetes.However, approval does not mean everyone meeting these criteria should automatically take the medication. A doctor must assess your health, medical history, and risks before prescribing it.Dr Brendan Hanrahan, an obesity medicine specialist at Brisbane's Wesley Hospital, welcomed wider access to the medication, saying GLP-1 drugs have "lived up to and exceeded the hype". However, he questioned whether BMI alone is enough to determine eligibility.He suggested waist circumference could offer some information about health risks, saying that some people may experience complications related to weight even when their BMI falls within the ‘normal’ healthy range.Side Effects And Risks Of Wegovy   The oral pill does not eliminate the side effects associated with semaglutide. Common adverse effects include:NauseaVomitingDiarrhoeaConstipationAbdominal discomfortHeadacheFatigueDizzinessGastrointestinal symptoms can sometimes lead to dehydration, which may increase the risk of kidney problems.The TGA also warns about more serious complications, including acute pancreatitis and diabetic retinopathy. People with diabetes, particularly those with pre-existing eye disease, may need clinical monitoring.Semaglutide is not recommended during pregnancy, and people planning to become pregnant should discuss treatment and timing with their doctor.The TGA has also warned of depression and suicidal thoughts or behaviours linked with GLP-1 medications.

australia approves first glp-1 weight loss pill: how it works & who is eligible

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Australia Approves First GLP-1 Weight Loss Pill: How It Works & Who Is Eligible

Early Breast Cancer: How to Make Space for Treatment Without Losing Sight of Yourself

Living Near Busy Roads? Traffic Noise May Raise Heart Disease Risk Even With Healthy Sleep

What Is Sad Nipple Syndrome? Could Hormones Trigger Sudden Sadness?

Health Conditions A-Z

Australia Approves First GLP-1 Weight Loss Pill: How It Works & Who Is Eligible

Beth Dobbin's Myalgic Encephalomyelitis Campaign Gains Support From 360 Sportspeople: Why Are They Urging UK PM To Act?

Early Breast Cancer: How to Make Space for Treatment Without Losing Sight of Yourself